Page 3 - ஒன்றுபட்டது கிஂக்டம் தரகு ஆன் மனிதன் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The UK has become the first country to authorise the Oxford-AstraZeneca COVID-19 vaccine for public use, with roll-out to start in the first week of 2021. This vaccine is the second to be authorised in the UK – following the Pfizer vaccine. The British government has ordered 100 million doses of the Oxford vaccine, enough to vaccinate 50 million people. Other countries will be watching closely: Australia has ordered over 50 million doses, Canada 20 million, and worldwide over 2.5 billion doses have been preordered. AstraZeneca expects to be able to supply large numbers of doses within the first quarter of 2021. Notably, British people will receive two full doses of the vaccine, which in trials prevented people from falling ill with COVID-19 62% of the time. This is despite trials initially suggesting that an alternative dosing strategy – using half a dose followed by a full dose – could be much more effective, preventing illness with 90% efficacy.

United kingdomOxford astrazenecaMichael headUniversity of southamptonUnited kingdom commission on human medicinesVaccine allianceHealthcare products regulatory agencyUnited kingdom medicinesHuman medicinesSaharan africaSoutheast asiaஒன்றுபட்டது கிஂக்டம்மைக்கேல் தலைபல்கலைக்கழகம் ஆஃப் சவுத்தாம்ப்டன்ஒன்றுபட்டது கிஂக்டம் தரகு ஆன் மனிதன் மருந்துகள்தடுப்பூசி கூட்டணி